The Evolution of Complement Inhibitor Treatment: Advancing PNH Therapy for Rare Blood Disorders
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematologic disorder characterized by complement-mediated hemolysis, leading to anemia, thrombosis, and significant morbidity. The advent of complement inhibitor treatment has revolutionized the management of PNH, transforming it from a life-threatening condition to a manageable chronic disease. The market for PNH...
0 Comments 0 Shares 3 Views 0 Reviews